Updated findings from a phase 3 study show significantly better 8-year progression-free survival with external beam radiation therapy added to androgen deprivation therapy (ADT) vs ADT alone.
A clinical trial sought to determine if a web-based patient decision making aid could improve satisfaction with care, reduce regrets, and improve alignment of risk category with treatment choice in men with localized prostate cancer.
